Related references
Note: Only part of the references are listed.National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection
D. A. Axelrod et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer
Pritesh S. Karia et al.
JAMA DERMATOLOGY (2016)
Association of Antibody Induction Immunosuppression With Cancer After Kidney Transplantation
Erin C. Hall et al.
TRANSPLANTATION (2015)
Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients
E. L. Yanik et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
New-onset diabetes mellitus after kidney transplantation: Current status and future directions
Sneha Palepu et al.
WORLD JOURNAL OF DIABETES (2015)
Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients
Krista L. Lentine et al.
TRANSPLANTATION (2014)
The Implications of Acute Rejection for Allograft Survival in Contemporary US Kidney Transplantation
Krista L. Lentine et al.
TRANSPLANTATION (2012)
The Implications of Acute Rejection and Reduced Allograft Function on Health Care Expenditures in Contemporary US Kidney Transplantation
Adrian Gheorghian et al.
TRANSPLANTATION (2012)
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
S. M. Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Solid Organ Allograft Survival Improvement in the United States: The Long-Term Does Not Mirror the Dramatic Short-Term Success
S. A. Lodhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
Eric A. Engels et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immunosuppression
Fu L. Luan et al.
TRANSPLANTATION (2011)
Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
Hallvard Holdaas et al.
TRANSPLANTATION (2011)
A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Mechanisms of Disease: Rejection of the Kidney Allograft.
Brian J. Nankivell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial
Markus Guba et al.
TRANSPLANTATION (2010)
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States
Vikas R. Dharnidharka et al.
TRANSPLANTATION (2009)
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period
F. L. Luan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure
Krista L. Lentine et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6-month course of steroids
M. Buechler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR study
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Infectious complications after kidney transplantation: current epidemiology and associated risk factors
George J. Alangaden et al.
CLINICAL TRANSPLANTATION (2006)
The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States
A Kutinova et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications
KL Lentine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Incidence and predictors of myocardial infarction after kidney transplantation
KL Lentine et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
T Mathew et al.
CLINICAL TRANSPLANTATION (2004)
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
RT Bustami et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cancer after kidney transplantation in the United States
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Diabetes mellitus after kidney transplantation in the United States
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: A report of the North American Pediatric Renal Transplant Cooperative Study
VR Dharnidharka et al.
PEDIATRIC TRANSPLANTATION (2002)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
Share Paper
